We are live on
!
Find out more
AB
Amalgamated Bank Portfolio holdings
AUM
$14.5B
1-Year Est. Return
44.3%
This Fund
S&P 500
This Quarter
Est. Return
+11.8%
1 Year Est. Return
+44.3%
3 Year Est. Return
+131.76%
5 Year Est. Return
+175.18%
10 Year Est. Return
+715.35%
AUM
$2.3B
AUM Growth
+$139M
(+6.4%)
Cap. Flow
-$51.8M
Cap. Flow
% of AUM
-2.25%
Top 10 Holdings %
Top 10 Hldgs %
21.5%
Holding
1,536
New
54
Increased
235
Reduced
1,203
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$7.66M |
| 2 |
Johnson Controls International
JCI
|
+$1.66M |
| 3 |
Willis Towers Watson
WTW
|
+$1.49M |
| 4 |
Amcor
AMCR
|
+$993K |
| 5 |
Match Group
MTCH
|
+$912K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$9.14M |
| 2 |
iShares Russell 3000 ETF
IWV
|
+$8.45M |
| 3 |
Apple
AAPL
|
+$5.08M |
| 4 |
Microsoft
MSFT
|
+$3.17M |
| 5 |
Amazon
AMZN
|
+$2.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.58% |
| 2 | Healthcare | 14.72% |
| 3 | Consumer Discretionary | 12.26% |
| 4 | Financials | 11.11% |
| 5 | Industrials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Hope Bancorp
HOPE
$1.79B
| $84K | ﹤0.01% |
11,137
-87
| -0.8% | -$728 |
|
1427
BioCryst Pharmaceuticals
BCRX
$2.35B
| $83K | ﹤0.01% |
24,276
+2,228
| +10% | +$9.55K |
|
1428
CoreCivic
CXW
$2.95B
| $83K | ﹤0.01% |
10,320
-107
| -1% | -$972 |
|
|
RWT
1429
Redwood Trust
RWT
$585M
| $81K | ﹤0.01% |
10,822
-106
| -1% | -$750 |
|
|
DHC
1430
Diversified Healthcare Trust
DHC
$2.17B
| $79K | ﹤0.01% |
22,387
-176
| -0.8% | -$687 |
|
|
QUOT
1431
DELISTED
Quotient Technology Inc
QUOT
| $79K | ﹤0.01% |
10,728
-220
| -2% | -$1.78K |
|
1432
Extreme Networks
EXTR
$3.9B
| $78K | ﹤0.01% |
19,429
-191
| -1% | -$831 |
|
|
CLVS
1433
DELISTED
Clovis Oncology, Inc.
CLVS
| $75K | ﹤0.01% |
12,918
+1,396
| +12% | +$8.35K |
|
|
IMGN
1434
DELISTED
Immunogen Inc
IMGN
| $72K | ﹤0.01% |
19,904
-289
| -1% | -$1.17K |
|
1435
Alaunos Therapeutics
TCRT
$4.59M
| $71K | ﹤0.01% |
187
-4
| -2% | -$1.77K |
|
|
VBIV
1436
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $69K | ﹤0.01% |
809
-18
| -2% | -$2.1K |
|
|
ATRS
1437
DELISTED
Antares Pharma, Inc.
ATRS
| $69K | ﹤0.01% |
25,414
-564
| -2% | -$1.56K |
|
1438
Archrock
AROC
$6.21B
| $66K | ﹤0.01% |
12,235
-110
| -0.9% | -$719 |
|
|
DVAX
1439
DELISTED
Dynavax Technologies
DVAX
| $66K | ﹤0.01% |
15,191
+1,948
| +15% | +$13.9K |
|
1440
Frontline
FRO
$8.7B
| $66K | ﹤0.01% |
+10,202
| New | +$78.2K |
|
1441
MannKind Corp
MNKD
$1.27B
| $64K | ﹤0.01% |
33,937
+223
| +0.7% | +$386 |
|
1442
BGC Group
BGC
$5.6B
| $63K | ﹤0.01% |
26,387
+90
| +0.3% | +$235 |
|
1443
Rigel Pharmaceuticals
RIGL
$704M
| $63K | ﹤0.01% |
2,628
-60
| -2% | -$1.47K |
|
|
DCH
1444
Dauch Corp
DCH
$1.39B
| $61K | ﹤0.01% |
10,615
-104
| -1% | -$744 |
|
1445
Ardelyx
ARDX
$1.25B
| $60K | ﹤0.01% |
11,371
-296
| -3% | -$1.78K |
|
1446
FuelCell Energy
FCEL
$1.89B
| $60K | ﹤0.01% |
937
-18
| -2% | -$1.43K |
|
1447
Amneal Pharmaceuticals
AMRX
$5.91B
| $59K | ﹤0.01% |
15,325
-359
| -2% | -$1.53K |
|
|
EIGI
1448
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $59K | ﹤0.01% |
10,221
-219
| -2% | -$1.23K |
|
1449
Akebia Therapeutics
AKBA
$362M
| $56K | ﹤0.01% |
22,266
+1,446
| +7% | +$12.7K |
|
1450
3D Systems Corp
DDD
$441M
| $55K | ﹤0.01% |
11,144
+102
| +0.9% | +$604 |
|
Similar funds
JFG
IFP
BBVA
SSA
BGC
FGP
Amalgamated Bank's Q3 2020 Portfolio in Review
As of Q3 2020, Amalgamated Bank held 1,536 positions worth $2.3B, up 6.4% from $2.16B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Amalgamated Bank's Q3 2020 filing shows 54 new, 235 increased, 1,203 reduced and 38 closed positions. Its largest new stake was Medtronic: 76,254 shares worth $7.92M. The largest sale was Accenture, an estimated $9.14M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Amalgamated Bank's largest Q3 2020 buy was Medtronic: 76,254 shares worth $7.92M.
- Amalgamated Bank added most to Match Group in Q3 2020, an estimated $912K increase.
- Amalgamated Bank's biggest Q3 2020 reduction was iShares Russell 3000 ETF, cutting an estimated $8.45M.
- Amalgamated Bank fully exited Accenture in Q3 2020, selling an estimated $9.14M.
- Amalgamated Bank's ten largest holdings make up 22% of its $2.3B portfolio in Q3 2020.
- Amalgamated Bank opened 54 new positions and closed 38 in Q3 2020.
- Amalgamated Bank's portfolio value rose 6.4% quarter-over-quarter to $2.3B.
Based on Amalgamated Bank's 13F filing for Q3 2020, filed 30 Oct 2020.